AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2021
Aug 3, 2021
35200_dirs_2021-08-02_e323f0df-1c6d-40a5-8e02-bcedd9f4d571.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-07-29
Reporting Person: Greenwood Luba (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-29 | Stock Option (right to buy) | $10.00 | A | 21000 | Acquired | 2031-06-30 | Common Stock (21000) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option shall vest on July 22, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such
date.